Pharmacologic aids to smoking cessation

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 11, 2000, Pages 818-824

  Helge, Trudy D ^b   Denelsky, Garland Y ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM;

CIGARETTE SMOKING; CLINICAL TRIAL; COUGHING; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; META ANALYSIS; MYALGIA; REVIEW; SKIN IRRITATION; SMOKING CESSATION; SUBSTITUTION THERAPY; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 0033749576     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.11.818     Document Type: Review

References (29)

1. Epstein LH, Grunberg NE, Lichtenstein E, Evans RI. Smoking research: basic research, intervention, prevention and new trends. Health Psychol 1989; 8:705-721.
2. Fiore MC, Pierce JP, Remington PL, et al. Cigarette smoking: the clinician's role in cessation, prevention, and public health. In: Disease-a-Month. Chicago: Year Book Medical Publishers; 1990:4.
3. DeNelsky GY, Bower ME. Smoking cessation in cardiac preventive health. In: Robin K, editor. Preventive Cardiology. Armonk, NY: Futura Publishing Company, 1998:325-353.
4. US Department of Health and Human Services. The health consequences of smoking: Nicotine Addiction. A report of the Surgeon General. Washington, DC: Office of Smoking and Health, 1998. US Department of Health and Human Services publication CDC 88-8406.
5. Schwartz JL. Review and evaluation of smoking cessation methods: The United States and Canada, 1978-1985. Bethesda, MD: US Department of Health and Human Services, 1987. National Institutes of Health publication 87-2940.
6. Lam W, Sze PC, Sacks HS, Chalmers TC. Meta-analysis of randomised controlled trials of nicctine chewing-gum. Lancet 1987; 2:27-29.
7. Law M, Tang LJ. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155:1933-1939.
8. Hughes JR, Goldstein MG, Hurt RD, Shiftman S. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281:72-76.
9. Hughes JR. Long-term use of nicotine-replacement therapy. In: Henningfield JE, Stitzer JL, editors. New Developments in Nicotine-Delivery Systems. New York: Carlton; 1991.
10. Hughes JR. Risk/benefit of nicotine replacement in smoking cessation. Drug Safety 1993; 8:49-56.
11. Fiore MC, Smith SS, Jorneby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: A metaanalysis. JAMA 1994; 271:1940-1947.
12. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343:139-142.
13. Kupecz D, Prochazka A. A comparison of nicotine delivery systems in a multimodality smoking cessation program. Nurse Practitioner 1996; 21:73-84.
14. Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993; 153:1881-1890.
15. Fiore MC, Jorneby DE, Baker TD, et al. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA 1994; 268:2687-2694.
16. Foulds J. Nicorette nasal spray: a novel nicotine therapy. Prescriber 1994; 19:21-25.
17. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dahl LC, Offord KP. Nicotine nasal spray for smoking cessation: Pattern of use, side effects, relief of withdrawal symptoms, and cotine levels. Mayo Clin Proc 1998; 73:118-125.
18. Hjalmarson A, Frazon M, Westin A, Wilkund O. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Intern Med 1994; 154:2567-2572.
19. Sutherland G, Stapleton J, Russell MAH, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340:324-329.
20. Bergstrom M, Nordberg A, Lunell E, Antoni G, Lanstrom B. Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther 1995; 57:309-317.
21. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O. The nicotine inhaler in smoking cessation. Arch Intern Med 1997; 157:1721-1728.
22. Goldstein MG. Bupropion sustained release and smoking cessation. J Clin Psychiatry 1998; 59(suppl 4):66-72.
23. Jorenby DE, Leischow SJ. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:695-691.
24. Ferry L, Burchette R. Evaluation of bupropion versus placebo for treatment of nicotine dependence [abstract]. In: New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association: May 26, 1994; Philadelphia. Abstract NR554:199-200.
25. Niaura R, Goldstein M, DePue J, et al. Fluoxetine, symptoms and depression, and smoking cessation. Ann Behav Med 1995; 17(suppl)S061.
26. Hurt RD, Sachs DPLO, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195-1202.
27. Clarke PBS. Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 1991; 86:501-505.
28. Hughes JR. Non-nicotine pharmacotherapies for smoking cessation. J Drug Develop 1994; 6:197-203.
29. Stolerman IP, Goldfarb T, Fink R, et al. Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 1973; 28:247-259.